Skip to content

Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology

Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02030470
Enrollment
36
Registered
2014-01-08
Start date
2014-06-01
Completion date
2018-03-01
Last updated
2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

Periodontitis, treatment, photodynamic, mid-term, bacteria

Brief summary

Periodontitis are infectious and inflammatory diseases of gum and tooth supporting tissues leading to tooth loss and oral disability. Twenty to 30 percents of patients treated for periodontal diseases display more or less pronounced persistence of periodontal tissue infection, inflammation, and destruction. The therapeutic additional value of photodynamic anti-infectious treatment remains controversial. The objective of this study is to evaluate the mid-term effect of the photodynamic device Fotosan®630 on severe periodontitis treatment outcomes and to define its specific therapeutic indications.

Interventions

OTHERFotosan®630. LED lamp. Toluidinblue. Photoactivated disinfection

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 40 years * signed informed consent * generalized severe chronic periodontitis * patient with at least 24 teeth * more than 30% of sites with clinical attachment loss \>5mm- at least 5 sites with pocket depth \>4mm per quadrant- at least one molar per quadrant- evidenced bone loss on radiographs- bleeding on probing ≥30%

Exclusion criteria

* aggressive periodontitis * smoking more than 10cig/day * patient with endocarditis risk or need of antibiotic prophylaxis * pregnant women * patient included in other trials * patient under guardianship * patient treated with antibiotics, anti-inflammatory, and other drugs (inhibitors of calcium channels…) influencing periodontal status within 6 months before examination * patient suffering from diseases influencing periodontal status (diabetes…) * patient periodontally treated with root planing or periodontal surgery within 1 year before examination * patient with scheduled extensive prosthetic treatment * patient with a high haemorrhagic risk (INR\>4) * impossible patient cooperation

Design outcomes

Primary

MeasureTime frameDescription
Change of periodontal pocket depth6 monthsStudy period for each participant : 6 months Inclusion period: 24 monthTotal study duration: 30 month

Secondary

MeasureTime frame
Change of periodontal clinical attachment level, gingival inflammation and dental plaque indexChange of periodontal microflora6 months

Countries

France

Contacts

PRINCIPAL_INVESTIGATORJean-Luc Davideau, MDPHD

Les Hôpitaux Universitaires de Strasbourg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026